JP2023513073A5 - - Google Patents
Info
- Publication number
- JP2023513073A5 JP2023513073A5 JP2022546537A JP2022546537A JP2023513073A5 JP 2023513073 A5 JP2023513073 A5 JP 2023513073A5 JP 2022546537 A JP2022546537 A JP 2022546537A JP 2022546537 A JP2022546537 A JP 2022546537A JP 2023513073 A5 JP2023513073 A5 JP 2023513073A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- hrsv
- glycoprotein
- lipids
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062967888P | 2020-01-30 | 2020-01-30 | |
| US62/967,888 | 2020-01-30 | ||
| PCT/US2021/015840 WO2021155243A1 (en) | 2020-01-30 | 2021-01-29 | Respiratory virus immunizing compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023513073A JP2023513073A (ja) | 2023-03-30 |
| JP2023513073A5 true JP2023513073A5 (https=) | 2024-07-01 |
Family
ID=77079256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022546537A Pending JP2023513073A (ja) | 2020-01-30 | 2021-01-29 | 呼吸器系ウイルス免疫化組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230338506A1 (https=) |
| EP (1) | EP4096683A4 (https=) |
| JP (1) | JP2023513073A (https=) |
| KR (1) | KR20220133911A (https=) |
| CN (1) | CN115103682A (https=) |
| AU (1) | AU2021214774A1 (https=) |
| BR (1) | BR112022015053A2 (https=) |
| CA (1) | CA3169664A1 (https=) |
| IL (1) | IL295148A (https=) |
| MX (1) | MX2022009429A (https=) |
| WO (1) | WO2021155243A1 (https=) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL4023249T3 (pl) | 2014-04-23 | 2025-03-10 | Modernatx, Inc. | Szczepionki z kwasem nukleinowym |
| MA42543A (fr) | 2015-07-30 | 2018-06-06 | Modernatx Inc | Arn épitope peptidiques concatémériques |
| US11564893B2 (en) | 2015-08-17 | 2023-01-31 | Modernatx, Inc. | Methods for preparing particles and related compositions |
| AU2016342045A1 (en) | 2015-10-22 | 2018-06-07 | Modernatx, Inc. | Human cytomegalovirus vaccine |
| EP4011451A1 (en) | 2015-10-22 | 2022-06-15 | ModernaTX, Inc. | Metapneumovirus mrna vaccines |
| AU2016341309A1 (en) | 2015-10-22 | 2018-06-07 | Modernatx, Inc. | Cancer vaccines |
| PL3386484T3 (pl) | 2015-12-10 | 2022-07-25 | Modernatx, Inc. | Kompozycje i sposoby dostarczania środków terapeutycznych |
| WO2017201342A1 (en) | 2016-05-18 | 2017-11-23 | Modernatx, Inc. | Polynucleotides encoding jagged1 for the treatment of alagille syndrome |
| CA3036831A1 (en) | 2016-09-14 | 2018-03-22 | Modernatx, Inc. | High purity rna compositions and methods for preparation thereof |
| EP3528821A4 (en) | 2016-10-21 | 2020-07-01 | ModernaTX, Inc. | HUMAN CYTOMEGALOVIRUS VACCINE |
| MA46766A (fr) | 2016-11-11 | 2019-09-18 | Modernatx Inc | Vaccin antigrippal |
| WO2018170245A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Broad spectrum influenza virus vaccine |
| EP3595713A4 (en) | 2017-03-15 | 2021-01-13 | ModernaTX, Inc. | RESPIRATORY SYNCYTIAL VIRUS Vaccine |
| WO2018170270A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Varicella zoster virus (vzv) vaccine |
| WO2018170256A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Herpes simplex virus vaccine |
| EP3595676A4 (en) | 2017-03-17 | 2021-05-05 | Modernatx, Inc. | RNA VACCINES AGAINST ZOONOSES |
| US11905525B2 (en) | 2017-04-05 | 2024-02-20 | Modernatx, Inc. | Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins |
| MA49421A (fr) | 2017-06-15 | 2020-04-22 | Modernatx Inc | Formulations d'arn |
| EP3668979A4 (en) | 2017-08-18 | 2021-06-02 | Modernatx, Inc. | METHOD OF HPLC ANALYSIS |
| MA49914A (fr) | 2017-08-18 | 2021-04-21 | Modernatx Inc | Procédés analytiques par hplc |
| WO2019036682A1 (en) | 2017-08-18 | 2019-02-21 | Modernatx, Inc. | RNA VARIANTS POLYMERASE |
| EP3675817A1 (en) | 2017-08-31 | 2020-07-08 | Modernatx, Inc. | Methods of making lipid nanoparticles |
| EP3746090A4 (en) | 2018-01-29 | 2021-11-17 | ModernaTX, Inc. | RSV RNA Vaccines |
| CA3113025A1 (en) | 2018-09-19 | 2020-03-26 | Modernatx, Inc. | Peg lipids and uses thereof |
| WO2020061295A1 (en) | 2018-09-19 | 2020-03-26 | Modernatx, Inc. | High-purity peg lipids and uses thereof |
| WO2020061457A1 (en) | 2018-09-20 | 2020-03-26 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
| US11851694B1 (en) | 2019-02-20 | 2023-12-26 | Modernatx, Inc. | High fidelity in vitro transcription |
| AU2020224103A1 (en) | 2019-02-20 | 2021-09-16 | Modernatx, Inc. | Rna polymerase variants for co-transcriptional capping |
| CN113874502A (zh) | 2019-03-11 | 2021-12-31 | 摩登纳特斯有限公司 | 补料分批体外转录方法 |
| US12070495B2 (en) | 2019-03-15 | 2024-08-27 | Modernatx, Inc. | HIV RNA vaccines |
| IL297419B2 (en) | 2020-04-22 | 2025-02-01 | BioNTech SE | Coronavirus vaccine |
| US11406703B2 (en) | 2020-08-25 | 2022-08-09 | Modernatx, Inc. | Human cytomegalovirus vaccine |
| WO2022099003A1 (en) | 2020-11-06 | 2022-05-12 | Sanofi | Lipid nanoparticles for delivering mrna vaccines |
| EP4274607A1 (en) | 2021-01-11 | 2023-11-15 | ModernaTX, Inc. | Seasonal rna influenza virus vaccines |
| WO2022221336A1 (en) * | 2021-04-13 | 2022-10-20 | Modernatx, Inc. | Respiratory syncytial virus mrna vaccines |
| US20220363937A1 (en) | 2021-05-14 | 2022-11-17 | Armstrong World Industries, Inc. | Stabilization of antimicrobial coatings |
| US12186387B2 (en) | 2021-11-29 | 2025-01-07 | BioNTech SE | Coronavirus vaccine |
| US12529047B1 (en) | 2021-12-21 | 2026-01-20 | Modernatx, Inc. | mRNA quantification methods |
| WO2024002985A1 (en) | 2022-06-26 | 2024-01-04 | BioNTech SE | Coronavirus vaccine |
| IL320459A (en) * | 2022-10-27 | 2025-06-01 | Pfizer | Rna molecules encoding rsv-f and vaccines containing them |
| WO2024193965A1 (en) * | 2023-03-17 | 2024-09-26 | Glaxosmithkline Biologicals Sa | Rsv-f-encoding nucleic acids |
| CN118108812B (zh) * | 2023-05-04 | 2025-04-15 | 国药中生生物技术研究院有限公司 | Rsv f蛋白的突变体 |
| WO2024231565A1 (en) * | 2023-05-10 | 2024-11-14 | Sanofi | Combination respiratory mrna vaccines |
| EP4736871A1 (en) * | 2023-06-21 | 2026-05-06 | Shenzhen Shenxin Biotechnology Co., Ltd. | Respiratory syncytial virus (rsv) vaccine |
| CN119979573A (zh) * | 2023-11-03 | 2025-05-13 | 纳美信(上海)生物科技有限公司 | 一种呼吸道合胞病毒mRNA疫苗 |
| CN117586359A (zh) * | 2024-01-19 | 2024-02-23 | 北京安百胜生物科技有限公司 | 一种具有免疫原性的呼吸道合胞病毒（rsv）多肽 |
| CN118064456B (zh) * | 2024-03-01 | 2024-10-29 | 嘉译生物医药(杭州)有限公司 | 一种针对人合胞病毒的新型的RSV B mRNA疫苗 |
| WO2025250938A2 (en) | 2024-05-31 | 2025-12-04 | Modernatx, Inc. | Respiratory syncytial virus and metapneumovirus vaccines |
| CN121620537A (zh) * | 2024-06-19 | 2026-03-06 | 厦门万泰沧海生物技术有限公司 | Rsv和hmpv融合f蛋白及其用途 |
| CN118480560B (zh) | 2024-07-09 | 2024-11-26 | 北京悦康科创医药科技股份有限公司 | 呼吸道合胞病毒mRNA疫苗及其制备方法和应用 |
| CN120118162B (zh) * | 2025-03-07 | 2026-03-10 | 深圳华大火眼工程科技有限公司 | 一种呼吸道合胞病毒的f蛋白突变体、其组合及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2445527A2 (en) * | 2009-06-24 | 2012-05-02 | ID Biomedical Corporation of Quebec | Vaccine |
| EP2970398B1 (en) * | 2013-03-13 | 2024-05-08 | The United States of America, as Represented by The Secretary, Department of Health and Human Services | Prefusion rsv f proteins and their use |
| EP4011451A1 (en) * | 2015-10-22 | 2022-06-15 | ModernaTX, Inc. | Metapneumovirus mrna vaccines |
| EA201891000A1 (ru) * | 2015-10-22 | 2018-12-28 | МОДЕРНАТиЭкс, ИНК. | Вакцина против респираторно-синцитиального вируса |
| WO2017172890A1 (en) * | 2016-03-29 | 2017-10-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Substitutions-modified prefusion rsv f proteins and their use |
| MA46766A (fr) * | 2016-11-11 | 2019-09-18 | Modernatx Inc | Vaccin antigrippal |
| WO2018107088A2 (en) * | 2016-12-08 | 2018-06-14 | Modernatx, Inc. | Respiratory virus nucleic acid vaccines |
| EP3595713A4 (en) * | 2017-03-15 | 2021-01-13 | ModernaTX, Inc. | RESPIRATORY SYNCYTIAL VIRUS Vaccine |
| HUE073526T2 (hu) * | 2017-04-04 | 2026-01-28 | Univ Washington | Önmagát összeállító fehérje nanostruktúrák, amelyek paramyxovírus és/vagy pneumovírus F fehérjéket jelenítenek meg és azok használata |
| EP3746090A4 (en) * | 2018-01-29 | 2021-11-17 | ModernaTX, Inc. | RSV RNA Vaccines |
| AU2019254591B2 (en) * | 2018-04-17 | 2025-12-11 | CureVac SE | Novel RSV RNA molecules and compositions for vaccination |
-
2021
- 2021-01-29 JP JP2022546537A patent/JP2023513073A/ja active Pending
- 2021-01-29 CN CN202180011671.6A patent/CN115103682A/zh active Pending
- 2021-01-29 BR BR112022015053A patent/BR112022015053A2/pt not_active Application Discontinuation
- 2021-01-29 EP EP21747384.2A patent/EP4096683A4/en active Pending
- 2021-01-29 AU AU2021214774A patent/AU2021214774A1/en not_active Abandoned
- 2021-01-29 KR KR1020227028349A patent/KR20220133911A/ko not_active Withdrawn
- 2021-01-29 WO PCT/US2021/015840 patent/WO2021155243A1/en not_active Ceased
- 2021-01-29 CA CA3169664A patent/CA3169664A1/en active Pending
- 2021-01-29 IL IL295148A patent/IL295148A/en unknown
- 2021-01-29 US US17/796,401 patent/US20230338506A1/en active Pending
- 2021-01-29 MX MX2022009429A patent/MX2022009429A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023513073A5 (https=) | ||
| JP2024503699A5 (https=) | ||
| DE112021000012C9 (de) | Coronavirus-Vakzine | |
| US11471525B2 (en) | Coronavirus vaccine | |
| JP2024503698A5 (https=) | ||
| US20230302112A1 (en) | Respiratory synctial virus rna vaccine | |
| AU2025205468A1 (en) | Messenger rna vaccines and uses thereof | |
| CA2751342C (en) | Lipid formulations comprising cationic lipid and a targeting lipid comprising n-acetyl galactosamine for delivery of nucleic acid | |
| JP2023531511A5 (https=) | ||
| CA3042927C (en) | Lipid compositions for the delivery of therapeutic agents | |
| JP2022535006A (ja) | 増殖ｔ細胞アッセイ | |
| JP2024514182A5 (https=) | ||
| JP2024542085A5 (https=) | ||
| CN116617382B (zh) | 新型冠状病毒疫苗及其制备方法和应用 | |
| US12263213B2 (en) | Compositions for use in treatment of Chlamydia | |
| KR20250099727A (ko) | 호흡기 세포융합 바이러스 rna 백신접종 | |
| JPWO2021251453A5 (https=) | ||
| Clark et al. | Respiratory syncytial virus vaccine approaches: a current overview | |
| JPWO2022244815A5 (https=) | ||
| WO2024260446A1 (zh) | 呼吸道合胞病毒(rsv)疫苗 | |
| CN118562832A (zh) | 编码HTNV包膜糖蛋白GP的基因、其编码的表达载体、mRNA分子及其用途 | |
| JP2025529906A (ja) | コロナウイルスに対するワクチン | |
| WO2025162490A1 (zh) | 一种新型mRNA疫苗的制备及其在治疗乙型肝炎病毒疾病药物组合中的应用 | |
| WO2024220742A9 (en) | Conjugated polyethyleneimine compounds and compositions, and uses thereof for the treatment of atherosclerosis, cardiovascular, and lung disease | |
| CN118159287A (zh) | 呼吸道合胞病毒rna疫苗 |